These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9302366)

  • 21. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
    Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
    J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 24. Eight clinical varieties for endocrine exophthalmos.
    Mortada A
    Bull Ophthalmol Soc Egypt; 1969; 62(66):371-84. PubMed ID: 5396087
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypofractionated radiotherapy for Graves' orbitopathy.
    Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
    Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
    Lai A; Sassi L; Compri E; Marino F; Sivelli P; Piantanida E; Tanda ML; Bartalena L
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1333-7. PubMed ID: 20061414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
    Campi I; Vannucchi GM; Minetti AM; Dazzi D; Avignone S; Covelli D; Currò N; Ratiglia R; Guastella C; Pignataro L; Beck-Peccoz P; Salvi M
    Ophthalmology; 2013 May; 120(5):1092-8. PubMed ID: 23399378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in exophthalmos after subtotal thyroidectomy for hyperthyroidism].
    Huo BZ; Du RY; Huang CT
    Zhonghua Wai Ke Za Zhi; 1988 Jan; 26(1):10-2, 59. PubMed ID: 3197529
    [No Abstract]   [Full Text] [Related]  

  • 30. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of Graves' disease and Graves' orbitopathy.
    Nagayama Y; Nakahara M; Abiru N
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):381-6. PubMed ID: 26181432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.
    Wiersinga W; Žarković M; Bartalena L; Donati S; Perros P; Okosieme O; Morris D; Fichter N; Lareida J; von Arx G; Daumerie C; Burlacu MC; Kahaly G; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    Eur J Endocrinol; 2018 Jun; 178(6):635-643. PubMed ID: 29650691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
    Smith TJ
    Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of Marine-Lenhart syndrome with unilateral endocrine orbitopathy and Hürthle cell carcinoma.
    Stanzel S; Gyürüs P; Kresnik E; Aigner R
    Nuklearmedizin; 2017 Aug; 56(4):N28-N30. PubMed ID: 28488725
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new echographic sign for the reliable diagnosis of graves' disease (author's transl)].
    Ossoinig KC
    Klin Monbl Augenheilkd; 1982 Mar; 180(3):189-97. PubMed ID: 7078008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
    Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment with inorganic iodine for Graves' hyperthyroidism].
    Noh JY; Chino T; Ito K
    Nihon Rinsho; 2006 Dec; 64(12):2269-73. PubMed ID: 17154090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graves' ophthalmopathy evaluated by infrared eye-movement recordings.
    Feldon SE; Unsöld R
    Arch Ophthalmol; 1982 Feb; 100(2):324-8. PubMed ID: 6895994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.